Nicole Onetto - May 27, 2025 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Director
Signature
/s/ William P. Quinn, Attorney-in-Fact
Stock symbol
BOLT
Transactions as of
May 27, 2025
Transactions value $
$0
Form type
4
Date filed
7/2/2025, 04:05 PM
Previous filing
Jun 14, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ONETTO NICOLE Director C/O BOLT BIOTHERAPEUTICS, INC., 900 CHESAPEAKE DRIVE, REDWOOD CITY /s/ William P. Quinn, Attorney-in-Fact 2025-07-02 0001220049

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +1.1K $0.00 1.1K May 27, 2025 Common Stock 1.1K $6.40 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 6, 2025, the Company effected a 1-for-20 reverse stock split of its common stock. All share and exercise price amounts reported herein reflect the reverse stock split. Prior to the reverse stock split, the reporting person was granted options to purchase 22,000 shares at an exercise price of $0.3200 per share.
F2 The shares subject to the option will vest on the earlier of May 27, 2026 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.